A RCT of Moist Ag Dressing in Chronic Wound
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorPeking University Third Hospital
About this trial
This study aims to explore the differences in efficacy and cost-effectiveness between self-adhesive soft polysilicone silver ion foam dressings and traditional silver dressings in local infected wounds through a prospective randomized controlled study. The goal is to provide evidence-based medical support for clinical application, further shorten the wound healing time, and reduce the economic burden on the medical system and patients.
Eligibility criteria
Qualifiers
The patient's age ranges from 18 to 80 years old.
According to the IWII wound infection staging, infected wounds are classified as local infections*.
The wound type is ulcer, with an ulcer area ranging from 1 to 40 cm².
The wound stage is in the necrosis stabilization phase, granulation growth phase, or epithelial crawling phase**.
Disqualifiers
Severe diseases such as acute myocardial infarction, heart failure, hepatitis, shock, and respiratory failure have not been corrected yet;
The blood sugar level of diabetes is out of control, with fasting blood sugar > 15 mmol/L and glycosylated hemoglobin ≥ 10%;
There is active bleeding in the wound, and the conventional basic treatment plan cannot be implemented;
Serum albumin < 20 g/L; hemoglobin < 60 g/L; platelets < 50 × 109/L;
Trial design
Treatments tested in this trial
- Ag foam dressing named MepilexAg
- Dry Ag dressing
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov